Hot Stocks Outlook for the Week of June 8th, 2018
The Hot Stocks Outlook uses VantagePoint market forecasts that are up to 86% accurate to demonstrate how traders can improve their timing and direction. In this week’s video, we analyze forecasts for Callon Petroleum ($CPE), VeriSign ($VRSN), Ralph Lauren Corporation ($RL), Guaranty Bancorp ($GBNK), and Progenics Pharmaceuticals ($PGNX).
This Week’s Hot Stocks Outlook
Callon Petroleum ($CPE) had a predictive moving average crossover to the downside in mid-May indicating a bearish trend. As soon as the blue line crossed below the black line, VantagePoint users knew they should start taking short positions in this market. The Neural Index also supported that move to the downside. In 15 trading days, $CPE was down almost 27% or $3.58 per share.
VeriSign ($VRSN) follows a similar pattern, but to the upside. The market had a crossover to the upside in early-May when that blue line made the cross above the black line. The neural index also reflected that short-term strength. All of this indicated to traders that the uptrend was beginning and to start going long in this particular market. Since that crossover, the market was up over 13% in 22 trading days or $15.79 per share.
Ralph Lauren Corporation ($RL) also had a bullish crossover in early-May. Despite whatever trading strategy that traders are following, that blue line crossed above the black line and was a clear indication that an uptrend was beginning. Despite an early period of consolidation, the trend was still bullish. Since that crossover 18 trading days ago, $RL was up 28.87% or $31.28 per share.
Guaranty Bancorp ($GBNK) follows the same idea. That market had a bullish crossover in early-May. Traders knew, with confidence, that they could begin going long in the market when the predictive indicators in VantagePoint showed that crossover to the upside. Despite some sideways movement early on, the trend was still very much to the upside. Since that crossover of the blue line 21 trading days ago, the market was up almost 20% or $5.72 per share.
Progenics Pharmaceuticals ($PGNX) is basically the same as the last 3. This market had a very clear crossover to the upside in early-May. When the blue line crossed above the black line, that’s when traders new the trend was beginning and to go long in the market. It’s that simple! In 21 trading days, Progenics Pharmaceuticals was up 28.62% or $1.97 per share.